Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Mol Carcinog. 2012 May 18;52(10):791–799. doi: 10.1002/mc.21923

Table 2.

Distribution of GAG repeat genotypes and lung and aerodigestive tract cancer risk

GAG Genotype Controls n (%) Lung Cancer Cases* Aerodigestive Tract Cancer Cases

n (%) OR (95% CI) n (%) OR (95% CI)
GAG-9/9 52 (9.6) 20 (5.7) 1.00 (reference) 9 (4.5) 1.00 (reference)
GAG-7/7 190 (35.3) 133 (38.3) 1.87 (1.00–3.51) 79 (39.5) 2.56 (1.16–5.63)
GAG-7/8 79 (14.7) 45 (12.9) 1.68 (0.83–3.42) 35 (17. 5) 2.60 (1.10–6.12)
GAG-7/9 155 (28.8) 102 (29.3) 1.67 (0.88–3.16) 55 (27.5) 1.94 (0.87–4.35)
GAG-8/8 15 (2.7) 6 (1.7) 1.16 (0.36–3.73) 5 (2.5) 1.83 (0.50–6.68)
GAG-8/9 32 (5.9) 23 (6.6) 2.23 (0.96–5.16) 16 (8.0) 3.09 (1.16–8.22)
GAG-4/4 0 2 (0.5) 0
GAG-7/10 9 (1.6) 12 (3.4) 0
GAG-8/10 1 (0.1) 1 (0.3) 0
GAG-9/10 2 (0.3) 3 (0.8) 0
GAG-4/9 0 0 1(0.5)
GAG-4/7 0 0 0
GAG-10/10 2(0.3) 0 0
*

OR adjusted for age, sex, body mass index and smoking history (categorical).

OR adjusted for age, sex, body mass index, smoking history (categorical) and the amount of alcohol intake.

Minor genotypes not included in statistical model.